Brighton Collaboration

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Brighton Collaboration" – news · newspapers · books · scholar · JSTOR (December 2017) (Learn how and when to remove this message) This article may need to be rewritten to comply with Wikipedia's quality standards. You can help. The talk page may contain suggestions. (September 2021) (Learn how and when to remove this message)

The Brighton Collaboration (BC) is a non-profit global vaccine safety research network based in Basel, Switzerland. It is named after the city in England where the idea was first formulated.^[2]

Key Information

Service Mark of the Brighton Collaboration Foundation
Formation	2000 (2000)
Type	NPO
Purpose	Safest, effective vaccines based on rigorous science To enhance the science of vaccine research by providing standardized, validated, and objective methods for continuous monitoring of safety profiles and by assessing benefit-risk ratios. These methods are, in turn, recognized and recommended for use by international regulatory and public health agencies.[1]
Headquarters	Basel, Switzerland
Region served	Worldwide
Official language	English
Leader	Jan Bonhoeffer, president
Parent organization	Task Force for Global Health
Affiliations	Coalition for Epidemic Preparedness Innovations
Website	brightoncollaboration.us
Show more

The Brighton Collaboration was launched in 2000, although the idea of the collaboration started one year earlier, following a presentation by Bob Chen at an international scientific vaccine conference in Brighton. In his talk, he stressed the need to improve vaccine safety monitoring by developing internationally accepted standards.^[3]

The Brighton Collaboration is a program of the Task Force for Global Health, a 501(c)(3) non-profit organization. It is primarily funded by the Coalition for Epidemic Preparedness Innovations (CEPI), and has received funding from a variety of scientific and public health organizations since its inception.^[4]

Non-funding partners of the Collaboration include the Council for International Organizations of Medical Sciences, European Medicines Agency, Food and Drug Administration and the World Health Organization.^[4]

This Switzerland-related article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e